View Author
scopus: 36978024600

Heijnsdijk, E.A.M.

( E.A.M. Heijnsdijk)


cancer screening model breast prostate prostate cancer mortality women study treatment breast cancer incidence mammography death trial stage overdiagnosi survival detection group estimate number effect screen population breast cancers breast cancer mortality result diagnosis disease breast cancer deaths state reduction mammography screening radiation erspc psa screening sensitivity table history interval tumor benefit breast cancer incidence 100 000 women difference research therapy health score biopsy gleason parameter absence progression breast cancer screening screen -film mammography follow-up european randomized study diameter rotterdam downloaded distribution netherland adjuvant frequency overdiagnosis rate period cure rate tumour screen-detected miscan stage-shift increase lifetime study group screening age onset control group biomarker




10 Most Recent Publications

Quality-of-life effects of prostate-specific antigen screening (Article)
Heijnsdijk, E.A.M. Wever, E.M. Zappa, M. Tammela, T.L. Mäkinen, T. Carlsson, S. Korfage, I.J. Essink-Bot, M.L.E. Otto, S.J. Draisma, G. Bangma, C.H. Roobol, M.J. Auvinen, A. Schröder, F.H. Koning, H.J. de Hugosson, J. Ciatto, S. Nelen, V. Kwiatkowski, M. Villers, A. Páez, A. Moss, S.M.
2012-08-16
Propensity score matching, competing risk analysis, and a competing risk nomogram: Some guidance for urologists may be in place (Article)
Roobol, M.J. Heijnsdijk, E.A.M.
2011-11-01
Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: A model-based approach on screening intervals (Article)
Ravesteyn, N.T. van Heijnsdijk, E.A.M. Draisma, G. Koning, H.J. de
2011-09-27
Digital mammography screening: Weighing reduced mortality against increased overdiagnosis (Article)
Gelder, R. de Fracheboud, J. Heijnsdijk, E.A.M. Heeten, G. den Verbeek, A.L.M. Broeders, M.J.M. Draisma, G. Koning, H.J. de
2011-09-01
Interpreting overdiagnosis estimates in population-based mammography screening (Article)
Gelder, R. de Heijnsdijk, E.A.M. Ravesteyn, N.T. van Fracheboud, J. Draisma, G. Koning, H.J. de
2011-07-01
How does early detection by screening affect disease progression?: Modeling estimated benefits in prostate cancer screening (Article)
Wever, E.M. Draisma, G. Heijnsdijk, E.A.M. Koning, H.J. de
2011-07-01
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models (Article)
Gulati, R. Wever, E.M. Etzioni, R. Tsodikov, A. Penson, D.F. Inoue, L.Y.T. Katcher, J. Lee, S.Y. Heijnsdijk, E.A.M. Draisma, G. Koning, H.J. de
2011-05-01
Racial disparities in breast cancer mortality - Response (Article)
Ravesteyn, N.T. van Schechter, C.B. Near, A.M. Heijnsdijk, E.A.M. Stoto, M.A. Draisma, G. Koning, H.J. de Mandelblatt, J.S.
2011-05-01
Population-based mammography screening below age 50: Balancing radiation-induced vs prevented breast cancer deaths (Article)
Gelder, R. de Draisma, G. Heijnsdijk, E.A.M. Koning, H.J. de
2011-03-29
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States (Article)
Ravesteyn, N.T. van Schechter, C.B. Near, A.M. Heijnsdijk, E.A.M. Stoto, M.A. Draisma, G. Koning, H.J. de Mandelblatt, J.S.
2011-01-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile